pH-Sensitive Nanoformulated Triptolide as a Targeted Therapeutic Strategy for Hepatocellular Carcinoma-Reference-Cited by-同舟云学术

pH-Sensitive Nanoformulated Triptolide as a Targeted Therapeutic Strategy for Hepatocellular Carcinoma

Published:2014-08-05 Issue:8 Volume:8 Page:8027-8039
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Ling Daishun¹²,Xia Hongping³,Park Wooram⁴,Hackett Michael J.¹²,Song Changyeong¹²,Na Kun⁴,Hui Kam Man³,Hyeon Taeghwan¹²

Affiliation:

1. Center for Nanoparticle Research, Institute for Basic Science (IBS), Seoul 151-742, Korea

2. School of Chemical and Biological Engineering, Seoul National University, Seoul 151-742, Korea

3. Laboratory of Cancer Genomics, Division of Cellular and Molecular Research, Humphrey Oei Institute of Cancer Research, National Cancer Center Singapore, Cancer and Stem Cell Biology Program, Duke-NUS Graduate Medical School, Department of Biochemistry, Yong Loo Lin School of Medicine, National University of Singapore, Institute of Molecular and Cell Biology, A*STAR, Biopolis Drive Proteos, Singapore 169610

4. Department of Biotechnology, The Catholic University of Korea, Bucheon-si, Gyeonggi-do 420-743, Korea

Funder

National Medical Research Council

Institute for Basic Science, Korea

Publisher

American Chemical Society (ACS)

Subject

General Physics and Astronomy,General Engineering,General Materials Science

Link

https://pubs.acs.org/doi/pdf/10.1021/nn502074x

Reference54 articles.

1. Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma